1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA LAMC3 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA ZCCHC4 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA CR2 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA COPS2 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CEBPE CTRPv2 pan-cancer AAC 0.089 0.01
mRNA FJX1 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA MUC3A CTRPv2 pan-cancer AAC 0.1 0.01
mRNA NEURL4 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA FBXW5 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA P4HA3 CTRPv2 pan-cancer AAC -0.089 0.01
Download CSV